Objectives: To assess the effect of oral gabapentin versus placebo on pain relief after gynecologic surgery.
Design: A triple blinded randomized clinical trial.
Setting and conduct: All eligible patients candidate for gynecologic surgery with hypogastric incision (hysterectomy, myomectomy, and ovarian cyst) who will refer to clinic of Besat Hospital during the study period will be enrolled in to the trial.
Inclusion criteria: (a) age of 18 to 65 years; (b) women with physical class ASA I-II; (c) candidate for elective gynecologic surgery.
Exclusion criteria: (a) contraindication for neuroaxial anesthesia; (b) history of hypertension or diabetes mellitus; (c) using narcotics or psychotropic.
Intervention: (a) 34 patients will receive two gabapentin capsules 300 mg (600 mg) single dose 2 hours before surgery; (b) 34 patients will receive one gabapentin capsule 300 mg plus one placebo capsule (containing starch) single dose 2 hours before surgery.
Control: 34 patients will receive two placebo capsules (containing starch) single dose 2 hours before surgery.
Primary outcome: (a) pain severity at surgical site at 1, 6, 12, 18, 24, and 48 hours after surgery using VAS scale; (b) the amount of narcotic used during the first 48 hours after surgery per mg; (c) the duration of time to receive narcotic the first narcotic during the first 48 hours after surgery per min.
Secondary outcome: (a) vertigo at 1, 6, 12, 18, 24, and 48 hours after surgery by question; (b) nausea and vomiting at 1, 6, 12, 18, 24, and 48 hours after surgery by question; (c) pruritus at 1, 6, 12, 18, 24, and 48 hours after surgery by question.